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Background: The incidence of acute otitis media (AOM) vary from country to country. Geographical variations
together with differences in study designs, reporting and settings play a role. We assessed the incidence of AOM in
Italian children seen by primary care paediatricians (PCPs), and described the methods used to diagnose the
disease.
Methods: This secondary data analysis from the Pedianet database considered children aged 0 – 6 years between
01/2003 and 12/2007. The AOM episodes were identified and validated by means of patient diaries. Incidence rates/
100 person-years (PY) were calculated for total AOM and for single or recurrent AOM.
Results: The 92,373 children (52.1% males) were followed up for a total of 227,361 PY: 23,039 (24.9%) presented
38,241 episodes of AOM (94.6% single episodes and 5.4% recurrent episodes). The total incidence rate of AOM in
the 5-year period was 16.8 episodes per 100 PY (95% CI: 16.7-16.9), including single AOM (15.9 episodes per 100 PY;
95% CI: 15.7-16.1) and recurrent AOM (0.9 episodes per 100 PY; 95% CI: 0.9-0.9). There was a slight and continuously
negative trend decrease over time (annual percent change −4.6%; 95%CI: -5.3, -3.9%). The AOM incidence rate
varied with age, peaking in children aged 3 to 4 years (22.2 episodes per 100 PY; 95% CI 21.8-22.7). The vast
majority of the AOM episodes (36,842/38,241, 96.3%) were diagnosed using a static otoscope; a pneumatic
otoscope was used in only 3.7%.
Conclusions: Our data fill a gap in our knowledge of the incidence of AOM in Italy, and indicate that AOM
represents a considerable burden for the Italian PCP system. Educational programmes concerning the diagnosis of
AOM are needed, as are further studies to monitor the incidence in relation to the introduction of wider
pneumococcal conjugate vaccines.
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Acute otitis media (AOM) is one of the most common
infectious diseases affecting infants and young children,
and one of the main reasons for antibiotic treatment
[1-4]. Its diagnosis is often challenging in everyday
practice because the symptoms are non-specific or
absent, and frequently little attention is paid to the
issued guidelines [5-7]. It is estimated that about two-* Correspondence: paola.marchisio@unimi.it
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reproduction in any medium, provided the orthirds of children aged less than three years have had at
least one episode of AOM, and about one-third have
had recurrences [8]. The impact on the pediatric health
care system is considerable at both societal and family
level [9].
The incidence of AOM varies from country to country
both because of geographical variations and of different
study designs, reporting and settings [10-15]. Annual
OM rates are still remarkably high in the USA, although
there has been a decline over the last decade since the
introduction of heptavalent pneumococcal vaccine [16].
The European data indicate a somewhat lower incidenceral Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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very few data relating to Italian children [17-20].
In the last decade the introduction of pneumococcal
conjugate vaccines has dramatically reduced invasive
pneumococcal diseases [21]. In light of the potential im-
pact also against non-invasive diseases such as middle
ear infections, there has been a continuing interest in
defining the incidence and burden of AOM in different
populations, including those in which the offer and
coverage of heptavalent pneumococcal conjugate vaccine
has been considerably heterogeneous [22-25].
The aims of this study were to assess the incidence of
AOM in Italian children seen by primary care pediatri-
cians (PCPs) and to describe the methods used to diag-
nose the disease.
Methods
Study design and setting
This secondary data analysis was based on data coming
from the Pedianet database (www.pedianet.it), a pediatric
general practice research database that contains the clinical,
demographic, prescription and outcome data of the chil-
dren routinely seen by about 130 PCPs equally distributed
throughout Italy (all Italian children aged less than six years
are registered with a PCP as part of the country’s
national health service), and which has been used for vari-
ous epidemiological and pharmacovigilance studies [26-29].
The data are generated during routine patient care using
common software (JuniorBit W), and are anonymously sent
monthly to a centralised database for validation. The rea-
sons for the contacts and diagnoses (free text or coded
using the ICD-9 system) are recorded in the medical file,
and the database also contains information about specialist
referrals, procedures, hospitalisations, medical examina-
tions, health status (according to the Guidelines of Health
Supervision of the American Academy of Pediatrics), and
centile diagrams. As of December 2008, the Pedianet data-
base stored data relating to 250,000 children, including the
findings of about 3,000,000 examinations, 2,600,000 diag-
noses, 1,800,000 drug prescriptions and 30,000 hospitalisa-
tions. The study and the access to the database were
approved by the Internal Scientific Committee.
Study population
All children aged 0–6 years who were registered with
one of the 108 out of 130 Pedianet PCPs who agreed to
participate in the study between January 1st, 2003 to De-
cember 31, 2007 were included. Any children whose par-
ents did not actively provide their informed consent
were excluded from the study.
Case definition and identification
The cases of AOM were initially identified from coded
diagnoses (ICD-9: 380 to 389). In order to identify anycases not reported in the diagnosis fields, we searched
the files describing hospitalisations, diagnoses, diaries,
specialist examinations and reasons for examinations
using a sensitive text string that included the words
“acute otitis”, “AOM”, “myringitis”, “ear pain”, “fever”,
“ear discharge”, “rhinitis”, and “vomiting”. Once identi-
fied, these cases were recoded using the ICD9 classifica-
tion. All of the potential episodes were manually
evaluated and validated in order to exclude any false
positive cases from the free text searches. The visits
were considered to be associated with a single AOM epi-
sode if they occurred within one month of the initial
diagnosis. One patient could have had more than one
episode of AOM if they were more than 30 days apart.
Recurrent otitis media (rAOM) was defined as a third
episode of AOM occurring within a period of six months
or a fourth episode occurring in a period of 12 months,
regardless of the age of the child.
The following information was sought in the clinical
record: the presence of any symptoms at the time of the
first examination and the diagnostic procedures used
(including static otoscopy, pneumatic otoscopy, tympa-
nometry, blood sampling for WBC counts and the rapid
determination of C-reactive protein level).
The cases of AOM were classified on the basis of diag-
nostic accuracy:
a) Level 1: diagnosed by a physician and documented as
such in the medical file or another source document
without any other specification;
b) Level 2: level 1 definition plus a report of the visual
appearance of the tympanic membrane (i.e. redness,
bulging, loss of light reflex), the presence of acute
middle-ear effusion (as shown by otoscopy or
tympanometry), and the presence of at least two of
the following signs or symptoms: ear pain, ear
discharge, cough, rhinitis, hearing loss, lethargy,
irritability, anorexia, vomiting, diarrhea, fever
(axillary temperature ≥38.0°C, rectal temperature
≥38,5°C) or analgesic/antipyretic therapy for
previous fever;
All of the children were followed from the date of
registration with the PCP, the date of birth, or the start
of the study period (whichever was the latest) until
death, moving away, or the age of six years, whichever
was the earliest.
Statistical analysis
The person-time of follow-up in the source population
was calculated by age group (0–1, 1–2, 2–3, 3–4, 4–5,
5–6 years) and calendar year, and formed the deno-
minator for calculating incidence. The cases (as defined
above) provided the numerator. The incidence of
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by the accrued person-time (patient-years, PY). Age,
gender and season-specific incidence rates were also cal-
culated. The 95% confidence intervals around the rates
were based on Poisson’s distribution. In order to char-
acterise the trend of the incidence rates over time, the
annual percent change (APC) was estimated using a
Poisson model with trigonometric factors accounting
for seasonality.
Results
Source population
The study population consisted of 92,373 children
(52.1% males) aged 0–6 years who were followed up for
a total of 227,361 PY: 23,039 children (24.9%) presented
38,241 primary diagnoses of AOM (36,180 single epi-
sodes [94.6%] and 2061 recurrent episodes [5.4%]).
The vast majority of AOM episodes (36,842/38,241;
96.3%) were classified as level 2 diagnostic accuracy,
which was strengthened by the fact that 34,138 (94.3%)
of the single episodes and 1892 (91.8%) of the recurrent
episodes was accompanied by the report of a sign or
symptom. The rest of the episodes were classified as
having level 1 diagnostic accuracy.
Incidence of AOM
Table 1 shows the incidence of AOM episodes by type of
AOM. The total rate in the 5-year period was 16.8 epi-
sodes per 100 PY, including single episodes (15.9 per 100
PY) and recurrent episodes (0.9 per 100 PY). The overall
incidence was slightly higher in males (16.5 episodes per
100 PY; 95% CI: 16.3-16.7) than in females (15.3 epi-
sodes per 100 PY; 95% CI: 15.0-15.5; p <0.001), but thereTable 1 Incidence rates of acute otitis media by year and typ
2003 2004
No. of children followed up 49782 53152
Person time (years) 41251.3 43459.5
Total AOM
No. of children 6614 5928
No. of episodes 8138 7173
Incidence rate* 19.7 (19.3-20.2) 16.5 (16.1-16.9) 15
Single AOM
No. of children 6438 5648
No. of episodes 7910 6729
Incidence rate* 19.2 (18.8-19.6) 15.5 (15.1-15.9) 14
Recurrent AOM
No. of children 176 280
No. of episodes 228 444
Incidence rate* 0.6 (0.5-0.6) 1.0 (0.9-1.1) 0
* Incidence rate (per 100 PY, 95% CI).was no gender-related difference in terms of recurrent
AOM (0.9 vs 0.9 episodes per 100 PY). The differences
in incidence by gender did not change substantially over
the years. The incidence was highest in the winter, but
also high in the autumn and spring (Figure 1). The long-
term rates showed a negative trend (APC −4.6%; 95%CI:
from −5.3 to −3.9%). Although most of the decrease oc-
curred in the first two years, Joinpoint regression did
not reveal any significant change in the trend.
Table 2 shows the incidence of AOM per 100 PY by
age group. The age group showing the highest rates of
single and recurrent AOM was 3–4 years, followed by
1–2 years, whereas the lowest rate was found in children
aged 5–6 years (Table 2). Seasonal variations were
observed at all ages (Figure 2).
Characteristics of AOM episodes
Table 3 shows the occurrence of symptoms by type of
AOM and age group. Ear pain was reported in 55.6% of
the children with single AOM and 50.4% of those with
recurrent AOM, and fever (≥38 °C) in respectively 49.9%
and 39.4%. Overall, the proportion of children with ear
pain increased with age, while the proportion of children
with fever decreased with age in both groups. Cough
was the third most commonly encountered symptom in
the children with single or recurrent AOM (26.9% vs
33.3%; p = <0.0001), being highest in younger children.
Spontaneous otorrhea was reported in about 6% of the
children in both groups.
Diagnostic methods
Most of the cases (96.3%) were diagnosed using a static
otoscope; pneumatic otoscopy was only used in 3.7% ofe of episode
2005 2006 2007 Total
58426 57092 55454 92373
48314.8 47956.7 46378.7 227361.0
6243 6490 6346 23039
7496 7815 7619 38241
.5 (15.2-15.9) 16.3 (15.9-16.7) 16.4 (16.1-16.8) 16.8 (16.7-16.9)
5951 6142 6023 21866
7084 7293 7164 36180
.7 (14.3-15.0) 15.2 (14.9-15.6) 15.4 (15.1-15.8) 15.9 (15.7-16.1)
292 348 323 1173
412 522 455 2061
.9 (0.8-0.9) 1.1 (1.0-1.2) 1.0 (0.9-1.1) 0.9 (0.9-0.9)
Figure 1 Incidence (per 100 PY) of AOM by month and year.
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Tympanometry was used as an adjunctive diagnostic
method in 1.2% of the single episodes and in 2.5% of the
recurrent episodes. Blood samples were drawn in a mi-
nority of children for WBC counts (0.3% of the single
episodes and 0.1% of the recurrent episodes) and C-
reactive protein levels (0.3% of the single episodes and
0.3% of the recurrent episodes).Table 2 Length of follow-up (person-time) and incidence rate
0-1 year 1-2 years 2-3 year
No. of children followed up 69289 40106 41332
Person time (years) 33241.9 37248.0 38950.5
Total AOM
No. of children 3807 5673 5107
No. of episodes 4709 7212 6180
Incidence rate* 14.2 (13.8-14.6) 19.4 (18.9-19.8) 15.9 (15.5-1
Single AOM
No. of children 3796 5576 5024
No. of episodes 4550 6703 5858
Incidence rate* 13.7 (13.3-14.1) 18.0 (17.6-18.4) 15.0 (14.7-1
Recurrent AOM
No. of children 118 333 216
No. of episodes 159 509 322
Incidence rate* 0.5 (0.4-0.6) 1.4 (1.3-1.5) 0.8 (0.7-0.
* Incidence rate (per 100 PY, 95% CI).Discussion
This is the first large-scale study describing the inci-
dence of AOM in Italian children diagnosed by PCPs.
The incidence slowly and slightly decreased between
2003 and 2007, with peaks fluctuating around 16%. The
seasonal incidence paralleled the seasonal variations in
upper respiratory tract infections. The age group show-
ing the highest rates of single and recurrent episodess by type of acute otitis media and age group
s 3-4 years 4-5 years 5-6 years Total
41683 41575 39921 92373
39798.1 40151.6 37970.9 227361.0
6991 5448 3935 21947
8848 6664 4628 38241
6.3) 22.2 (21.8-22.7) 16.6 (16.2-17.0) 12.2 (11.8-12.5) 16.8 (16.7-17.0)
6915 5330 3855 21866
8376 6285 4408 36180
5.4) 21.0 (20.6-21.5) 15.7 (15.3-16.0) 11.6 (11.3-12.0) 15.9 (15.7-16.1)
347 272 171 1173
472 379 220 2061
9) 1.2 (1.1-1.3) 0.9 (0.9-1.0) 0.6 (0.5-0.7) 0.9 (0.9-0.9)
Figure 2 Incidence (per 100 PY) of AOM by age (year) and calendar year.
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5–6 years.
Strengths and limitations
The main strength of this study is the use of data cover-
ing a five-year period taken from a validated research
database of a large national network of PCPs, who have
been used to collaborating in order to produce epi-
demiological data for the most common diseases over
the last ten years [26-29]. One of the main strengths ofTable 3 Occurrence of symptoms (%) in children with single a
0 – 1 year 1 - 2 years 2-3 years
AOM* rAOM° AOM rAOM AOM rAOM
Total number of
episodes
4550 159 6703 509 5858 322
Total number with ≥1
symptom
3650
(80.2)
132
(83.0)
6424
(95.8)
446
(87.6)
5635
(96.2)
262
(81.3)
Ear pain 15.7 14.3 26.7 24.1 57.4 58.5
Fever ≥38 °C 60.3 54.9 63.4 50.6 52.2 37.1
Cough 36.9 49.5 35.0 39.8 27.0 35.4
Rhinitis 16.2 14.3 15.7 11.1 10.6 11.4
Otorrhea 6.8 5.5 6.7 6.5 5.9 6.6
Vomiting 2.9 3.3 3.2 2.2 2.3 0.9
*AOM: single acute otitis media; ° rAOM; recurrent acute otitis media.Pedianet is the reliability of its baseline population of
children registered with individual PCPs working within
the Italian national health service. This allowed the inci-
dence of AOM to be calculated on the basis of person-
time by age groups, and provides a precise picture of the
disease in the field. Furthermore, as it was a secondary
data analysis, no diagnostic criteria were imposed and
the cases were identified on the basis of real-world indi-
vidual PCP criteria, and therefore reflects the real diag-
nostic and management approach of Italian PCPs tond recurrent acute otitis media by age group
3-4 years 4-5 years 5-6 years Total
AOM rAOM AOM rAOM AOM rAOM AOM rAOM
8376 472 6285 379 4408 220 36180 2061
8338
(99.5)
435
(92.2)
6048
(96.2)
355
(93.7)
4043
(91.7)
173
(78.6)
34138
(94.3)
1892
(91.8)
68.7 57.0 76.3 74.8 79.6 66.9 55.6 50.4
46.4 37.1 40.5 26.8 36.0 33.9 49.9 39.4
24.5 33.9 20.9 24.4 18.4 17.3 26.9 33.3
8.5 7.3 8.0 5.7 7.2 5.5 10.8 9.0
4.8 5.6 4.7 6.5 4.7 3.9 5.5 6.0
2.3 2.1 2.4 0.8 2.1 0.8 2.5 1.6
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episodes of AOM were reviewed and validated: the cases
were not just based on coded diagnoses, but traced by
means of a manual search in the clinical record. Finally,
the study period preceded the introduction of the Italian
AOM guidelines [30], thus avoiding another possible
confounding factor capable of having an impact on PCP
behaviour.
The study has a few limitations, including its retro-
spective nature and the fact that the PCPs may not have
used the same definition of AOM. Some epidemiological
variables associated with an increased risk of AOM, such
as exposure to passive smoking, number of siblings, day
care attendance or prolonged use of a pacifier [31,32],
were not recorded but this was beyond the scope of
the study.
There was also no information concerning the
pneumococcal or influenza vaccination status of the
children. Heptavalent pneumococcal conjugate vaccine
was gradually introduced into Italy in late 2005 [33],
with different regions adopting different policies that
varied from the vaccination of specific groups to the vac-
cination of all infants. However, about half of the PCPs
participating in the study were working in regions in
which it was initially recommended only for specific
high-risk groups, and it is unlikely that the lack of the
information regarding vaccination would have been a
major confounding factor in such a setting.
We did not record episodes of AOM not seen by PCPs
but diagnosed in an Emergency Room (ER). However, as
PCPs are free of charge in Italy, it is likely that only a
negligible proportion of children would have only been
seen in an ER.
Finally, we did not study the severity of the AOM epi-
sodes because, although important, there is no consen-
sus concerning the best clinical severity score [29].
Comparison with other studies
The incidence of AOM is lower than that reported in
Northern Europe [34-36] and the USA [37,38], but simi-
lar to the rates observed in The Netherlands [19] and
the Czech Republic [22]. The prospective cohort EPI
AOM study found similar differences between the inci-
dence of AOM in Italy and four other European coun-
tries in 2008 [20]: the incidence of AOM in children
aged less than five years was 19.5% (95% CI 17.1-22.2%)
in Italy, which is not remarkably higher than that
described here (16.8%). This finding, which could have
been expected given the retrospective design of our
study, is quite reassuring about the validity of our data.
There are several possible explanations for the lower
incidence rates observed in our population. We only
considered validated episodes and not visits; further-
more, multiple examinations within 30 days of the firstreported diagnosis were considered as being related to
just one episode (although these were reported very
rarely). The better climate of Italy in comparison with
Northern Europe may also be a factor, but this does not
apply to Spain. The functioning of the Italian NHS,
which provides specialised primary care to all children
free of charge and is funded by paying PCPs on the basis
of the number of children registered with them, regard-
less of the number of accesses, avoids any possible risk
that they increased the number of visits to increase their
income or that parents avoided seeking care for eco-
nomic reasons. We cannot exclude the possibility that at
least a few AOM cases were seen in an ER without being
first reported by a PCP, but these would very likely have
been identified because a follow-up examination by a
PCP is very often recommended after ER discharge.
The lower incidence of AOM in Italy cannot be attrib-
uted to parents not consulting a physician as a result of
the 2004 introduction of the US guidelines on AOM [2],
which suggested observation without the use of antibio-
tics, because it has been demonstrated that Italian pedia-
tricians do not generally follow these recommendations
[7]. In addition, racial factors, known to influence the in-
cidence of severe and chronic suppurative otitis media
in selected racial groups such as Australian aboriginal
children and Native Americans, cannot be an explan-
ation because they have no role in the incidence of
AOM in white children [39,40]. Finally, it is unlikely that
there was an impact of influenza vaccine, known to be
able to reduce the incidence of AOM [41], because influ-
enza vaccine is not routinely recommended for Italian
children and only a few are actually vaccinated [42].
Pediatric OM consultations have decreased in Europe
and the US over the last 10 years [11,16,43-45]. The
slight but continuous decrease over time in our popula-
tion is very similar to that observed in other surveillance
studies. One possible confounder may have been the
introduction of heptavalent pneumococcal vaccine in
late 2005: however, any change before then cannot be
attributed to the vaccine and, in the post-introduction
period, there was no obviously accelerated decrease in
the incidence of AOM. It can be speculated that the low
heptavalent pneumococcal vaccine coverage in the im-
mediate post-introduction would not have had a sub-
stantial impact on AOM in the population as a whole.
The peak incidence of AOM was in children aged 3–
4 years. This conflicts with published reports indicating
that children aged up to two years are most frequently
affected by AOM. It is likely that the risk arising from
exposure to other children was less in our survey
because day care attendance in Italy typically begins at
three years of age and the small size of the average
Italian family (2.47 members) [46] reduces the risk of
exposure to other children in the youngest age groups.
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in our study did not present ear pain or fever. This find-
ing (which may be partially due to under-reporting in
the database) is in line with those of previous studies
[47,48] and supports the need for diagnostic otoscopic
skills to avoid the risk of underestimating true AOM.
On the other hand, cough and rhinitis were present in
more than one-third of the children, thus supporting the
belief that OM begins as a viral infection of the naso-
pharynx and the Eustachian tube and is therefore part of
a more wide-ranging respiratory disease [49]. Otorrhea
affected a minority of the children: however, this finding
is important because it is believed that children with a
spontaneously perforated tympanic membrane are more
likely to have a poor outcome [50]. Finally, vomiting was
present in 2% of cases: this prevalence is lower than that
observed in other studies, but the difference can be
explained by the fact that we required actual gastrointes-
tinal vomiting and not mucous vomiting [48].
Only a minority of the PCPs reported using a pneu-
matic otoscope, which is considered the primary diag-
nostic method by most AOM guidelines. This is
consistent with the finding of our previous survey con-
cerning the use of diagnostic instruments by Italian phy-
sicians [7]. Most Italian PCPs refer the most severe or
recurrent cases of AOM (and all cases of OM with effu-
sion) to an otolaryngologist, and it is therefore likely that
they do not feel the need for more accurate diagnostic
instruments.
We found it surprising that WBC counts and rapid C-
reactive protein testing were included in the diagnostic
work-up of children with AOM as it has been demon-
strated that they are not useful in differentiating viral
from bacterial episodes [51]. However, it is possible that,
in these limited cases, the hematological evaluation was
made because of the concomitant presence of a second-
ary infection.
Conclusions
In brief, our data (which are confirmed by the results of
a smaller prospective study) fill a gap in our knowledge
concerning the incidence of AOM in Italy and indicate
that it represents a considerable burden on the Italian
PCP system. Educational programmes concerning the
diagnosis of AOM are needed, as are further studies to
monitor incidence in relation to the introduction of
wider pneumococcal conjugate vaccines.
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